Navigation Links
Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839

to cause long-term sensitization and irritancy. No sensitization reactions were recorded in any of the subjects, and low irritancy potential was confirmed. Additionally, in all Phase I studies no serious adverse events were observed in any study subject.

About REP8839

REP8839 is a novel topical antibacterial ointment that targets the bacterial methionyl tRNA (MetRS) enzyme. MetRS is an unexploited target in clinically-important Gram-positive bacteria and represents a promising platform for the development of new antibacterial agents with no cross-resistance to currently marketed antibiotics. In vitro, REP8839 is highly active against major skin pathogens such as Streptococcus pyogenes and Staphylococcus aureus (S. aureus), including drug-resistant strains such as MRSA, mupirocin-resistant and vancomycin-resistant S. aureus.

About Impetigo

Impetigo is a contagious skin disorder caused by bacterial infection and characterized by crusting, red skin lesions, most frequently affecting children. It is the third most common skin disease in children, causing peak incidence among those aged two to five years. Since 2004, the incidence of impetigo has increased 21 percent. In 2006, topical antibiotic prescriptions accounted for 48 percent of all impetigo treatments.

About Replidyne, Inc.

Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products. Replidyne's lead product, faropenem medoxomil, is a novel oral, community antibiotic, expected to be appropriate for use as a first-line antibiotic for treatment of respiratory and skin infections in adult and pediatric patients. Replidyne's second drug candidate, REP8839, is a topical anti-infective product candidate in development for the treatment of skin and wound infections, including methicillin-resistant S. aureus (MRSA) infections. Replidyne is also pursuing the development of other novel anti-infect
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Replidyne Phase II Pediatric Trial Meets Primary Objective
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:7/31/2014)... July 31, 2014 TB Alliance, a not-for-profit ... affordable treatments for tuberculosis (TB), announced the appointment of ... Access. Ms. Robertson joins the organization from Novartis Vaccines, ... Sub-Saharan Africa and Eastern Europe . ... Alliance,s efforts to ensure beneficial new TB treatments are ...
(Date:7/31/2014)... und KISSING, Deutschland, 31. Juli 2014 ... Distributor eines computerunterstützten („robotischen") Koloskopie-Systems für den ... Shamir , ein weltweit anerkannter Manager im ... Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener globaler Visionär der ...
(Date:7/31/2014)... , July 31, 2014  Celsion Corporation (NASDAQ: ... host a conference call to discuss its second quarter ... August 7, 2014. To participate in the call, interested ... ) or 1-785-830-1924 (International/Toll) and ask for the Celsion ... to register ten minutes before the call is scheduled ...
Breaking Medicine Technology:TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3Celsion Corporation to Hold Second Quarter 2014 Financial Results 2
... N.J. and LACHEN, Switzerland, Sept. 26, 2011 ... largest human protein products manufacturers in the world, has ... efficacy and safety of wilate® (von Willebrand ... post-operative bleeding in pediatric and adult patients with Type ...
... Accuray Incorporated (Nasdaq: ARAY ), the premier ... to present at the JMP Securities Healthcare Conference in New ... a.m. PDT. A live webcast of the presentation ... the Company,s website at http://www.accuray.com . The webcast replay ...
Cached Medicine Technology:Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 2Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 3
(Date:7/31/2014)... Bedford Commons OB-GYN partnered ... Brand ReEnergizers to do what Christina Haag, the ... with the community all while still offering the greatest ... caters to women’s health needs for every stage of ... focused care ( Gynecology ), worked diligently with their ...
(Date:7/31/2014)... Today, Good Neighbor Pharmacy reinforced ... care by kicking off another year of programs ... of many education sessions and initiatives took place ... Neighbor Pharmacy and AmerisourceBergen’s annual conference. Sessions around ... Star Measures were a highlight and helped pharmacists ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Ticket Down ... Bolivia tickets at Dick’s Sporting Goods Park in suburban ... the Mexican national soccer team has found a second home ... failures during their time playing international friendly games and will ... at Dick’s Sporting Goods Park in Commerce City, Colorado. The ...
(Date:7/31/2014)... By Amy Norton ... -- They may not have had fast food, TVs or ... arteries -- and a new research review speculates on some ... ancient Egypt, Peru, the Aleutian Islands and the American Southwest, ... of heart arteries from fatty substances that build up, eventually ...
(Date:7/31/2014)... Fitness on the Go in-home ... which now includes Ottawa along with all major cities ... fitness to clients in Ontario since 2012, but have ... a Canadian owned in-home fitness and personal training company ... and fitter lifestyle. , Fitness on the Go makes ...
Breaking Medicine News(10 mins):Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 2Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 4Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 3Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 2Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 3Health News:Fitness on the Go Grows to Ottawa 2
... , ... as one of Northeast Ohio,s 99 great workplaces for top talent , ... Hudson, OH (PRWEB) September 2, 2009 -- Lexi-Comp, ... systems, has been selected as one of Northeast Ohio,s 99 great workplaces for top talent. ...
... ... from the soft economy: large amounts of vacancies make today a perfect time to begin ... (PRWEB) September ... reported in the LA Times they "are swimming in empty space." James Helsel, Treasurer of ...
... Medicare annual enrollment ... ... you’re one of the more than 45 million people relying on Medicare for healthcare coverage, ... expensive, according to Allsup , a nationwide provider of Social Security disability representation and ...
... HARBIN, China, Sept. 1 /PRNewswire-Asia-FirstCall/ -- SOKO Fitness & Spa,Group, ... beauty salons and spas in Northeast China, today announced record,financial results ... Fiscal 2009 highlights:, -- Revenue increased ... increased 36% year-over-year to $7.0 million, -- Gross ...
... , LAWRENCE, Mass., Sept. 1 NxStage ... innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive ... the UBS Global Life Sciences Conference on Tuesday, September 22, 2009 ... , NxStage,s investor presentation is scheduled for Tuesday, ...
... REDMOND, Wash., Sept. 1 Aegis Living, a ... assisted living communities , has been chosen as the "Best Retirement ... the first-ever "Best of 425" reader poll, thousands responded to vote ... innovative ways to improve health, quality of life, well-being and sense of ...
Cached Medicine News:Health News:Lexi-Comp, Inc. Receives NorthCoast 99 Honor 2Health News:Lexi-Comp, Inc. Receives NorthCoast 99 Honor 3Health News:Lexi-Comp, Inc. Receives NorthCoast 99 Honor 4Health News:Today's Economy Forces Landlords to Get Aggressive...Tenants Reap the Rewards 2Health News:Today's Economy Forces Landlords to Get Aggressive...Tenants Reap the Rewards 3Health News:Today's Economy Forces Landlords to Get Aggressive...Tenants Reap the Rewards 4Health News:Allsup Outlines 10 Critical Questions to Answer When Evaluating Medicare Plans 2Health News:Allsup Outlines 10 Critical Questions to Answer When Evaluating Medicare Plans 3Health News:Allsup Outlines 10 Critical Questions to Answer When Evaluating Medicare Plans 4Health News:Allsup Outlines 10 Critical Questions to Answer When Evaluating Medicare Plans 5Health News:SOKO Fitness & Spa Group Announces Record Financial Results for Fiscal Year; Sets Conference Call to Discuss Results 2Health News:SOKO Fitness & Spa Group Announces Record Financial Results for Fiscal Year; Sets Conference Call to Discuss Results 3Health News:SOKO Fitness & Spa Group Announces Record Financial Results for Fiscal Year; Sets Conference Call to Discuss Results 4Health News:SOKO Fitness & Spa Group Announces Record Financial Results for Fiscal Year; Sets Conference Call to Discuss Results 5Health News:SOKO Fitness & Spa Group Announces Record Financial Results for Fiscal Year; Sets Conference Call to Discuss Results 6Health News:SOKO Fitness & Spa Group Announces Record Financial Results for Fiscal Year; Sets Conference Call to Discuss Results 7Health News:SOKO Fitness & Spa Group Announces Record Financial Results for Fiscal Year; Sets Conference Call to Discuss Results 8Health News:SOKO Fitness & Spa Group Announces Record Financial Results for Fiscal Year; Sets Conference Call to Discuss Results 9Health News:NxStage to Present at the UBS Global Life Sciences Conference 2Health News:Aegis Living Chosen as Best Retirement Facility in 2009 Best of 425 magazine 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: